| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/26/2008 | CN101147612A Five health-care soft beverage |
| 03/26/2008 | CN100376583C Esters in position 20 of camptothecins |
| 03/26/2008 | CN100376573C 1,3-dihydroimidazole fused-ring compound |
| 03/26/2008 | CN100376572C Anti-infective agents |
| 03/26/2008 | CN100376562C Production of furanones |
| 03/26/2008 | CN100376530C Vitamin D analogues |
| 03/26/2008 | CN100376288C Improvement of T cell mediated immunity |
| 03/26/2008 | CN100376275C Chinese medicine powder for treating AIDS |
| 03/26/2008 | CN100376255C Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatary activity and anti-atherogenic activity |
| 03/26/2008 | CN100376250C Clamycin fast release micropill and its preparation method |
| 03/26/2008 | CA2561104A1 Antimicrobial agents derived from cream |
| 03/25/2008 | US7348433 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction |
| 03/25/2008 | US7348423 Nucleic acids encoding fusion peptides |
| 03/25/2008 | US7348409 Antimicrobially active peptide |
| 03/25/2008 | US7348359 Retinoid X receptor modulators |
| 03/25/2008 | US7348357 bactericide; derivatives of pseudopeptide Andrimid in which beta-phenylalanine amide is replaced by heteroaromatic or substituted aromatic amide; N-{(1S)-3-[((1S)-1-{[(3R,4S)-1,4-Dimethyl-2,5-dioxo-3-pyrrolidinyl]carbonyl}-2-methylpropyl)amino]-3-oxo-1-phenylpropyl}-2-pyridinecarboxamide; antibiotics |
| 03/25/2008 | US7348350 Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesirable microorganisms |
| 03/25/2008 | US7348345 Nonnucleoside reverse transcriptase inhibitors |
| 03/25/2008 | US7348341 Chemical compounds |
| 03/25/2008 | US7348336 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 03/25/2008 | US7348327 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 03/25/2008 | US7348324 Cyclic amine compounds as CCR5 antagonists |
| 03/25/2008 | US7348318 α-Amino-N-(diaminophosphinyl)lactam derivatives |
| 03/25/2008 | US7348317 Aqueous compositions containing metronidazole |
| 03/25/2008 | US7348177 Expression of HIV polypeptides and production of virus-like particles |
| 03/25/2008 | US7348148 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 03/25/2008 | US7348012 Methods and vaccines for providing in ovo protection against turkey rhinotracheitis |
| 03/25/2008 | US7348006 histidine to improve pH stability, adjuvant adsorption, and reduce antigen hydrolysis in vaccines using aluminum salt(s) |
| 03/25/2008 | US7347995 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients |
| 03/25/2008 | CA2484638C Polyene polyketides and methods of production |
| 03/25/2008 | CA2419077C A method of treating a systemic disease |
| 03/25/2008 | CA2370446C Pharmaceutical compounds |
| 03/25/2008 | CA2277273C Integrin antagonists |
| 03/25/2008 | CA2268709C Hiv protease inhibitors |
| 03/25/2008 | CA2264822C Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 03/25/2008 | CA2243578C High affinity nucleic acid ligands of complement system proteins |
| 03/25/2008 | CA2203652C A method of down-regulating gene expression |
| 03/25/2008 | CA2073500C Compositions and methods for detecting and modulating rna activity and gene expression |
| 03/20/2008 | WO2008033851A2 Use of 2-6- (3-amino-piperidin-l-yl) -3-methyl-2, 4-dioxo-3, 4-dihydr0-2h-pyrimidin-1-ylmet hyl-4-fluoro-benzonitrile |
| 03/20/2008 | WO2008033389A2 Macrocyclic hcv inhibitors and their uses |
| 03/20/2008 | WO2008033278A1 Heterosubstituted n-thiolated beta-lactam compounds and methods of use |
| 03/20/2008 | WO2008033159A1 Influenza antibodies, compositions, and related methods |
| 03/20/2008 | WO2008033105A1 Hemagglutinin antibody and uses thereof |
| 03/20/2008 | WO2008032847A1 External preparation for skin |
| 03/20/2008 | WO2008032817A1 Sugar chain having activity against helicobacter pylori |
| 03/20/2008 | WO2008032796A1 Novel vaccine for dog |
| 03/20/2008 | WO2008032783A1 Artificial antibacterial peptide and use thereof |
| 03/20/2008 | WO2008032777A1 Antibacterial peptide and use thereof |
| 03/20/2008 | WO2008032665A1 Novel phenylacetic acid derivative |
| 03/20/2008 | WO2008032153A2 Calreticulin for its use as a medication for the treatment of cancer in a mammal |
| 03/20/2008 | WO2008031878A1 A composition for therapy and/or for prophylaxis of hbv-infections and hbv-mediated diseases |
| 03/20/2008 | WO2008031788A1 Aminoazepine derivatives as highly efficient inhibitors of the inducible nitric oxide synthase |
| 03/20/2008 | WO2008031315A1 The use of solidago virgaurea in the preparation of a medicament for treatment and prevention of a virus |
| 03/20/2008 | WO2008014108A3 Antimicrobial oxazolidinone prodrugs |
| 03/20/2008 | WO2008008907A3 Antiviral agents |
| 03/20/2008 | WO2008001212A3 Penem prodrugs |
| 03/20/2008 | WO2007140154A3 Salts and crystal modifications thereof |
| 03/20/2008 | WO2007113648A3 Ctla4 antibody combination therapy |
| 03/20/2008 | WO2007054085A3 Antiviral agent comprising tribomechanically activated zeolite (tmaz), propolis, and colostrum |
| 03/20/2008 | US20080071233 Pharmaceutical compositions |
| 03/20/2008 | US20080071069 For delivering DNA/RNA into cells |
| 03/20/2008 | US20080070981 Water-soluble compositions of bioactive lipophilic compounds |
| 03/20/2008 | US20080070969 [3.2.0] heterocyclic compounds and methods of using the same |
| 03/20/2008 | US20080070966 1-methyl-3-(2-oxo-2-octyloxyethyl)-1H-Imidazolium bromide; imidazolium ionic liquids and non-ionic or anionic surfactants; stable antimicrobial activity; preservation of personal care and cosmetic products |
| 03/20/2008 | US20080070954 inhibitors of histone deacetylase; antiproliferative; anticancer; 8-[3-(4-methylbenzenesulfonyl)-ureido])-octanoic acid hydroxyamide |
| 03/20/2008 | US20080070951 Viricides; HIV antivirals effective against problematic drug escape mutants; N-[(1S,1aR,7bR)-4,7-difluoro-1,1a,2,7b-tetrahydrocyclopropa[c]chromen-1-yl]-N'-[5-(4-(sulfonamido)phenoxy)-2-pyridinyl]urea |
| 03/20/2008 | US20080070937 Small molecule inhibitors of kynurenine-3-monooxygenase |
| 03/20/2008 | US20080070935 Isoquinoline, Quinazoline and Phthalazine Derivatives |
| 03/20/2008 | US20080070933 Purine, Pyrimidine, and Azaindole Derivatives |
| 03/20/2008 | US20080070930 2-(4-oxo-4,5,6,7-tetrahydroindol-1-yl) or 2-(4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl) pyrimidines or pyrazines; cancer, inflammation, arthritis, angiogenesis, fungal, viral and Plasmodium infections; Heat Shock Protein 90 inhibitors |
| 03/20/2008 | US20080070920 Novel HIV reverse transcriptase inhibitors |
| 03/20/2008 | US20080070918 Heat Shock Protein-90 (HSP-90) inhibitors; cancer, inflammation, arthritis, angiogenesis, antimalaria, fungal and viral infections; 2-(4-Hydroxy-cyclohexylamino)-4-(3,7,7-trimethyl-5-oxo-5,6,7,8-tetrahydro-4H-cinnolin-1-yl)-benzamide for example; synthesis from corresponding benzonitriles |
| 03/20/2008 | US20080070910 aromatic or heterocyclic/heterobicyclic carbamate compounds as protease inhibitors , useful for inhibiting the development of drug resistance of HIV in HIV infected animals; improved pharmacokinetics; protease inhibitors |
| 03/20/2008 | US20080070908 Compositions including antibiotics and methods for using same |
| 03/20/2008 | US20080070907 Substituted chiral fused [1,2] imidazo [4,5-C] ring compounds and methods |
| 03/20/2008 | US20080070905 An enzyme in the tryptophan degradation pathway, used to treat neurodegenerative disorders, certain cancers, drug addiction; 2-sulfonamido-substituted oxazole, imidazole or thiazole compounds such as 3,4-dimethoxy-N-[4-(3-nitrophenyl)-5-dimethylaminomethyl-1,3-thiazole-2-yl]benzenesulfonamide |
| 03/20/2008 | US20080070901 Cholineterase inhibitors for treating inflammation |
| 03/20/2008 | US20080070897 Having high bioavailability levels and reduced variability of bioavailability by use of dispersed, colloidal structures, colloids or analogous structures of the drug, a hydrophilic component (ethanol) , a surfactant such as polyglycerol, polyoxyethylene castor oil |
| 03/20/2008 | US20080070862 Methods using glycosaminoglycans for the treatment of nephropathy |
| 03/20/2008 | US20080070861 Therapy for infections such as hepatitis virus using a (2'R)-2'-deoxy-2'-fluoro-2'-C-methyl nucleosides; rhinovirus; Dengue virus (DENV) or West Nile virus |
| 03/20/2008 | US20080070859 Treats neoplastic disorders, infections from fungal or fungal-like organisms and other parasites |
| 03/20/2008 | US20080070854 Conserved Hbv and Hcv Sequences Useful for Gene Silencing |
| 03/20/2008 | US20080070852 Immunomodulators; therapy and prophylaxis of infections caused by adenovirus, cytomegalovirus, hepatitis A virus (HAV), hepatitis B virus (HBV), flaviviruses including Yellow Fever virus, herpes virus; 5-Amino-3-(5'-O-L-valinyl- beta -D-ribofuranosyl)thiazolo[4,5-d]pyrimidine-2,7-dione Dihydrochloride |
| 03/20/2008 | US20080070850 Have a linker molecule that misaligns the carbohydrate cores; structurally simpler, easier to synthesize, and more potent; low toxicity; anticancer; 1,1'-O-2,2',3,3',4,4',6,6'-tetrakis(3,4,5-trihydroxybenzoyl)- beta , beta '-D,D'-glucopyranosylterephthalate |
| 03/20/2008 | US20080070846 Treating acute exacerbations of asthma using a ketolide |
| 03/20/2008 | US20080070305 Inhibition of expression of a target gene |
| 03/20/2008 | US20080070279 Group of Synthetic Antimicrobal Peptides |
| 03/20/2008 | US20080070259 Using presence or absence of mutation in metalloenzyme polynucleotides as diagnostic indicator of cardiovascular and neurodegenerative disorders |
| 03/20/2008 | US20080070258 Polyamide nucleic acid derivatives and agents, and processes for preparing them |
| 03/20/2008 | US20080069870 Pulsed release; oral administering |
| 03/20/2008 | US20080069866 Immunotherapeutic methods and compositions |
| 03/20/2008 | US20080069849 Genetic engineered polypeptide; bactericides, viricides, fungicides, parasiticides |
| 03/20/2008 | US20080069844 Mucosal Vaccine Adjuvants Containing Bacterial Flagellins as an Active Component |
| 03/20/2008 | US20080069843 Prevention of microbial pathogenesis; administering mixture of mutant Salmonella bacteria and carrier |
| 03/20/2008 | US20080069842 Vaccines for Mycoplasma bovis and methods of use |
| 03/20/2008 | US20080069838 Novel human virus causing severe acute respiratory syndrome (sars) and uses thereof |
| 03/20/2008 | US20080069837 Composition and method for treating cancer using herpes virus |
| 03/20/2008 | US20080069835 Diphtheria, tetanus, diphtheria, deactivated polio virus, hepatitis B surface antigen in container with protein carrier |
| 03/20/2008 | US20080069832 Shiga-like toxin which binds to receptor; complexing with antigen |
| 03/20/2008 | US20080069825 Multiple CpG oligodeoxynucleotides and their use to induce an immune response |